Puma Biotechnology, Inc. is a company in the U.S. stock market and it is a holding in 35 U.S.-traded ETFs. PBYI has around 4.9M shares in the U.S. ETF market. The largest ETF holder of PBYI is the SPDR S&P Biotech ETF (XBI), with approximately 2.30M shares. Investors may also find of interest that the ETF with the largest allocation to PBYI stock is Virtus LifeSci Biotech Products ETF (BBP), with a portfolio weight of 1.61%. On average, U.S. ETFs allocate 0.10% of PBYI to their portfolios.
Additionally, PBYI is a favorite stock for Vanilla and Fundamental ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with PBYI as a holding is the ALPS Medical Breakthroughs ETF (SBIO), with a return of 19.89%.